Topics

Mirati details early results for KRAS inhibitor MRTX849 http://www.firstwordpharma.com/node/1677061  $MRTX

06:24 EDT 29 Oct 2019 | FirstWord Pharma

Mirati details early results for KRAS inhibitor MRTX849 http://www.firstwordpharma.com/node/1677061 

Original Article: Mirati details early results for KRAS inhibitor MRTX849 http://www.firstwordpharma.com/node/1677061  $MRTX

NEXT ARTICLE

More From BioPortfolio on "Mirati details early results for KRAS inhibitor MRTX849 http://www.firstwordpharma.com/node/1677061  $MRTX"

Quick Search